Stopping Cancer cells from repairing themselves after radiotherapy
Identify a new drug combination that will be able to block the ability of cancer cells to repair themselves after radiotherapy treatment.
Tag: New treatment | Past Project
Dr Hind Hafsi is carrying out preclinical analyses of a novel anti-cancer agent aimed at enhancing the radiation response in head and neck cancer patients at the Institute of Cancer Research. This project which is seeking to identify a new drug combination that will be able to block the ability of cancer cells to repair themselves after radiotherapy treatment.
The project is being generously funded by the Bender Foundation and is expected to be completed in autumn 2016.
Whilst radiotherapy is an effective treatment for all sorts of cancers, it is also possible for some cancer cells to repair themselves after being targeted with radiation. So, if it was possible to use a drug combination which prevents this ‘self-repair’ it would mean radiotherapy could lead to 100% cell death.
Dr Hind Hafsi is carrying out research for Oracle to discover whether a pioneering new drug combination will be able to block the ability of cancer cells to repair themselves. This is the first project of its kind using this particular drug combination.
Help us beat cancer
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Dr Hind Hafsi
Length of project:
Get in touch
Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.